|
    SLGC U.S.: Nasdaq

    SomaLogic Inc.

    Watchlist
    NEW
    Set a price target alert
    SLGCUS
    After Hours
    Last Updated: Dec 1, 2023 5:07 p.m. EST Delayed quote

    $ 2.8100

    -0.02 -0.71%
    After Hours Volume: 12.07K
    Close Chg Chg %
    $2.8300 0.0100 0.35%
    Advanced Charting
    Volume: 1.73M 65 Day Avg: 1.48M
    117% vs Avg
    2.7600 Day Range 2.8850
    1.7300 52 Week Range 3.7900

    Partner Center

    Your Watchlists

    Customize MarketWatch

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    No Saved Watchlists

    Create a list of the investments you want to track.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    SLGC Overview

    Key Data

    • Open $2.8000
    • Day Range 2.7600 - 2.8850
    • 52 Week Range 1.7300 - 3.7900
    • Market Cap $530.36M
    • Shares Outstanding 188.07M
    • Public Float 156.46M
    • Beta 1.69
    • Rev. per Employee $181.21K
    • P/E Ratio N/A
    • EPS -$0.6988
    • Yield N/A
    • Dividend N/A
    • Ex-Dividend Date N/A
    • Short Interest 7.68M 11/15/23
    • % of Float Shorted 4.91%
    • Average Volume 1.48M

    Performance

    5 Day
    • 4.43%
    1 Month
    • 25.22%
    3 Month
    • 25.22%
    YTD
    • 12.75%
    1 Year
    • -2.41%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 4 Full Ratings

    Recent News

    SomaLogic Climbs as Standard BioTools Declines on All-Stock Merger

    SomaLogic’s stock surges as it agrees to be bought by Standard BioTools in all-stock merger

    SomaLogic to Merge With Standard BioTools in All-Stock Deal

    SomaLogic stock price target cut to $8 from $12 at Stifel Nicolaus

    SomaLogic started at buy with $12 stock price target at Stifel Nicolaus

    Hold Rating Maintained for SomaLogic Amidst Strong Performance and Pending LAB Acquisition

    on TipRanks.com

    Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    on Benzinga.com

    Disney, Twilio, TransDigm, Marathon Digital And Other Big Stocks Moving Higher On Thursday

    on Benzinga.com

    Recap: SomaLogic Q3 Earnings

    on Benzinga.com

    Earnings Scheduled For November 8, 2023

    on Benzinga.com

    Earnings Outlook For SomaLogic

    on Benzinga.com

    12 Health Care Stocks Moving In Monday's Pre-Market Session

    on Benzinga.com

    An Analyst With 83% Accuracy Rate Expects 6% Upside In Alphabet — Here Are 5 Stock Picks From Wall Street's Most Accurate Analysts

    on Benzinga.com

    12 Health Care Stocks Moving In Thursday's After-Market Session

    on Benzinga.com

    Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023

    on Benzinga.com

    Hold Rating on SomaLogic Post-Merger: A Strategic Move Shadowed by Stock Performance Uncertainty

    on TipRanks.com

    Why SomaLogic Stock Dived by 10% on Wednesday

    on Motley Fool

    Cathie Wood's Ark Invest Sells Nearly $4M Worth Of NVIDIA Shares — Does It Herald Shift To Undervalued AI Gems?

    on Benzinga.com

    Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023

    on Benzinga.com

    3 Stocks Cathie Wood Is Buying That Should Be on Your List, Too

    on Motley Fool

    Cathie Wood Continues To Unload DraftKings Shares, Picks Up Robinhood Stock Worth $4.75M

    on Benzinga.com

    Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    on Benzinga.com

    Why Shares of SomaLogic Are Up Tuesday

    on Motley Fool

    Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday

    on Benzinga.com

    SomaLogic (SLGC) Receives a Rating Update from a Top Analyst

    on TipRanks.com

    SomaLogic Inc.

    SomaLogic, Inc. is a commercial-stage proteomics company, which built an integrated proteomics platform for robust, high throughput proteomics analysis, research and clinical applications. The company was founded by Larry Gold in 2000 and is headquartered in Boulder, CO.